Tower Research Capital LLC (Trc) Novartis Ag Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Novartis Ag stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 11,197 shares of NVS stock, worth $1.18 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
11,197
Previous 102
10877.45%
Holding current value
$1.18 Million
Previous $11,000
9800.0%
% of portfolio
0.02%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding NVS
# of Institutions
1,462Shares Held
132MCall Options Held
1.33MPut Options Held
1.54M-
Dodge & Cox San Francisco, CA12.2MShares$1.29 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.16 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$863 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$724 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$588 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $227B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...